États-Unis · Plateformes & données · MarketBeat
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Stock Has Average Price Target of $12.00

Résumé détaillé
Shares of SAB Biotherapeutics, Inc. (NASDAQ:SABS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has given a h
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)


